What is Us Pharmatech?
US Pharmatech Inc. stands as a prominent manufacturer within the dietary supplement sector, offering comprehensive OEM and private label services. The company excels in providing end-to-end solutions, encompassing product creation, packaging, labeling, and distribution. Boasting an extensive library of over 10,000 existing formulas and a robust R&D division responsible for developing more than 40,000 unique formulations, US Pharmatech caters to a diverse clientele seeking high-quality nutraceutical and supplement manufacturing. Their capabilities span both solid and liquid product forms, positioning them as a versatile partner for businesses aiming to launch or scale their supplement lines.
How much funding has Us Pharmatech raised?
Us Pharmatech has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Us Pharmatech?
The company's recent major strategic investment, within the context of large-scale late-stage funding, signals a pivotal moment for Us Pharmatech. This capital infusion is likely earmarked for scaling manufacturing operations, expanding research and development initiatives, and potentially broadening its market reach through strategic partnerships or acquisitions. The focus on OEM and private label services suggests a strategy centered on empowering other brands, and this latest financing will undoubtedly enhance their capacity to serve a growing client base and innovate within the competitive nutraceutical landscape.
See full Us Pharmatech company page
